| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/27/2013 | WO2013096157A1 Bioseparation compositions and methods for making and using same |
| 06/27/2013 | WO2013095759A1 Assessing renal structural alterations and outcomes |
| 06/27/2013 | WO2013095730A2 Multimode platform for detection of compounds |
| 06/27/2013 | WO2013095691A1 Tube and reflective float systems for analyzing suspensions |
| 06/27/2013 | WO2013095367A1 Diagnostic methods |
| 06/27/2013 | WO2013095305A1 Bodipy structure fluorescence probes for diverse biological applications |
| 06/27/2013 | WO2013095303A1 A microarray and method for forming the same |
| 06/27/2013 | WO2013095284A1 Method and device for measuring a component in exhaled breath |
| 06/27/2013 | WO2013095203A1 Procedure for controlling pulp quality from refiners |
| 06/27/2013 | WO2013095159A1 Method of detecting oil spill at the sea by means of an oil spill radar, and such an oil spill radar |
| 06/27/2013 | WO2013095137A2 Methods, means and kits for detecting scarce analytes |
| 06/27/2013 | WO2013095091A2 Rsv g protein specific antibodies |
| 06/27/2013 | WO2013095082A1 Fruit ripeness detection and collection system and method thereof |
| 06/27/2013 | WO2013095014A1 Method for detecting compound-binding protein |
| 06/27/2013 | WO2013094773A1 Methods of prognosis and diagnosis in sepsis |
| 06/27/2013 | WO2013094316A1 Micro-/nanofluidic analyzer and method for manufacturing same |
| 06/27/2013 | WO2013094307A1 Exosome analysis method, reagent for use in analysis of exosome, and exosome analysis apparatus |
| 06/27/2013 | WO2013094080A1 Recombinant protein capable of specifically and rapidly binding to troponin-i originated from human cardiac muscles |
| 06/27/2013 | WO2013093942A2 Method and device for moisture determination and control |
| 06/27/2013 | WO2013093913A1 Spectroscopic means and methods for identifying microorganisms in culture |
| 06/27/2013 | WO2013093888A1 Electrochemical sensors |
| 06/27/2013 | WO2013093812A2 A rapid quantitative assay to measure cftr function in a primary intestinal culture model |
| 06/27/2013 | WO2013093792A1 A sensing membrane for sensing parameters of an organic fluid during its flowing in an extracorporeal circuit |
| 06/27/2013 | WO2013093722A1 Combination assay device and method for detecting compounds in vaginal fluid |
| 06/27/2013 | WO2013093671A1 Identification of atypical antibodies in human blood and blood products |
| 06/27/2013 | WO2013093642A1 Method for labeling intracellular and extracellular targets of leukocytes |
| 06/27/2013 | WO2013093512A2 Vaccine - screening method |
| 06/27/2013 | WO2013093507A1 Assay of functional cell viability |
| 06/27/2013 | WO2013093489A2 Detection and treatment of breast cancer |
| 06/27/2013 | WO2013093483A1 A method for identifying a target polymer |
| 06/27/2013 | WO2013093481A1 Fluorescent dyes based on acridine and acridinium derivatives |
| 06/27/2013 | WO2013093345A1 Method for detecting an infection by the hepatitis c virus |
| 06/27/2013 | WO2013093115A2 Marker sequences for breast cancer and the use thereof |
| 06/27/2013 | WO2013093079A1 Mao-b inhibitors derived from the one-carbon cycle |
| 06/27/2013 | WO2013093071A1 A method for on-line control of a manufacturing process for a multicomponent sheet material |
| 06/27/2013 | WO2013093024A1 Multilayered woven manufacture and use of the multilayer woven manufacture as carriers for dried matrix spot applications |
| 06/27/2013 | WO2013093016A1 Diagnosis of steatohepatitis |
| 06/27/2013 | WO2013093015A1 Diagnosis of steatohepatitis |
| 06/27/2013 | WO2013093013A1 Massive parallel test of molecular interactions on the basis of magnetic nanoparticles and microparticles |
| 06/27/2013 | WO2013092992A1 Novel luminescent lanthanide chelates with enhanced excitation properties |
| 06/27/2013 | WO2013092952A2 Method for selectively quantifying a-beta aggregates |
| 06/27/2013 | WO2013092951A2 Standard for quantifying pathogenic aggregates from proteins produced naturally in the body |
| 06/27/2013 | WO2013092845A1 Method for determining an analyte concentration |
| 06/27/2013 | WO2013092793A1 Screening methods to identify compounds useful in the prevention and/or treatment of inflammatory conditions |
| 06/27/2013 | WO2013092774A1 High-density fluorescent dye clusters |
| 06/27/2013 | WO2013092742A1 Method for patient selection |
| 06/27/2013 | WO2013092611A2 Method for the detection of free binding partner of a multispecific binder |
| 06/27/2013 | WO2013092509A1 Inhibitors of sialoadhesin for the treatment of diseases caused by enveloped viruses |
| 06/27/2013 | WO2013092480A1 In vitro 3d-reporter skin model |
| 06/27/2013 | WO2013092412A1 Soluble st2 as a marker for risk of mortality in hiv-infected subjects |
| 06/27/2013 | WO2013092166A1 Sensor system and method for recording a measurement variable |
| 06/27/2013 | WO2013092018A1 Method for monitoring a broadband lamdba probe |
| 06/27/2013 | WO2013091924A1 Applications of an immune system-released activating agent (israa) |
| 06/27/2013 | WO2013091883A2 Selective gpcr ligands |
| 06/27/2013 | WO2013091637A1 Optimized insect-based ex vivo model for testing blood-brain barrier penetration and method for exposing insect brain to chemical compounds |
| 06/27/2013 | WO2013091623A1 Method for monitoring the compliance of a predetermined desired concentration of a first component in an article consisting of a thermoplast, and first component of a thermoplast |
| 06/27/2013 | WO2013091113A1 A method of predicting outcome in cancer patients |
| 06/27/2013 | WO2013091103A1 Single domain antibodies as inhibitors of pcsk9 |
| 06/27/2013 | WO2013091074A1 Method and array for identifying histone-code-related analytes |
| 06/27/2013 | WO2013066408A3 Clear margin determination during cancer surgery |
| 06/27/2013 | WO2013061083A3 Therapeutic agents and uses thereof |
| 06/27/2013 | WO2013057323A3 Marker and target for responsiveness and resistance to cancer agents |
| 06/27/2013 | WO2013052946A9 Genetically encoded biosensors |
| 06/27/2013 | WO2013040062A3 Characterizing multiple sclerosis |
| 06/27/2013 | WO2013038412A3 Antibodies directed against signal peptides, methods and uses thereof |
| 06/27/2013 | WO2013033705A3 Non-natural nucleosides as theranostic agents |
| 06/27/2013 | WO2013033609A3 Methods and compositions for the treatment and diagnosis of cancer |
| 06/27/2013 | WO2013003849A4 Process and apparatus for quantifying nucleic acid in a sample |
| 06/27/2013 | WO2012160091A3 Sensor device for detecting an analyte |
| 06/27/2013 | WO2012159754A3 Individualized vaccines for cancer |
| 06/27/2013 | WO2012149299A3 Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor |
| 06/27/2013 | WO2012140621A3 Analysing device for urine |
| 06/27/2013 | WO2012135841A3 Emt signatures and predictive markers and method of using the same |
| 06/27/2013 | US20130167255 Screening method for anticancer drugs |
| 06/27/2013 | US20130165633 Endogenous and Non-Endogenous Versions of Human G Protein-Coupled Receptors |
| 06/27/2013 | US20130165501 Lipid Binding Nucleic Acids |
| 06/27/2013 | US20130165442 Modulators of ATP-Binding Cassette Transporters |
| 06/27/2013 | US20130165345 Method for assaying peritonitis in humans |
| 06/27/2013 | US20130165344 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 06/27/2013 | US20130165342 Methods and systems for extending dynamic range in assays for the detection of molecules or particles |
| 06/27/2013 | US20130165341 Structure-activity relationships |
| 06/27/2013 | US20130165340 Multiplex colon cancer marker panel |
| 06/27/2013 | US20130165339 Sapp-alpha as a biomarker for prediction of inflammatory and autoimmune-related disorders |
| 06/27/2013 | US20130165338 Biomarkers for determination of temporal phase of acute kidney injury |
| 06/27/2013 | US20130165332 Compositions and methods for the treatment of immune related diseases |
| 06/27/2013 | US20130165329 Multimode systems and methods for detecting a sample |
| 06/27/2013 | US20130164859 Dna-decorated graphene chemical sensors |
| 06/27/2013 | US20130164858 Diagnostic detection device |
| 06/27/2013 | US20130164855 Method of monitoring thrombus formation |
| 06/27/2013 | US20130164854 Disposable cartridge for fluid analysis |
| 06/27/2013 | US20130164853 Method for Prevention of Contamination |
| 06/27/2013 | US20130164779 Disposable cartridge for fluid analysis |
| 06/27/2013 | US20130164769 Method for quantifying the amount of cholesterol in high-density lipoprotein 3 |
| 06/27/2013 | US20130164768 Method of lipid assay and reagent for use therein |
| 06/27/2013 | US20130164767 Assays for human nt-pro b-type natriuretic peptide, human pro b-type natriuretic peptide and human b-type natriuretic peptide |
| 06/27/2013 | US20130164766 Isolation and Application of BAD-1 For Diagnosing Infections With Blastomyces Dermatitidis |
| 06/27/2013 | US20130164765 Method and system for diagnosis of lawsonia intracellularis |
| 06/27/2013 | US20130164764 Methods of Detection of Coccidioides Species in Bodily Fluid |
| 06/27/2013 | US20130164763 Analysis device and method using the same |
| 06/27/2013 | US20130164762 Prognostic test of the progression of a solid tumour by image analysis |